The impact of regulatory restrictions on pregabalin use in Saudi Arabia: An interrupted time series analysis.
Turki Abdulaziz AlthunianMaha I AlomranGhada M AlsagriMeshael M AlrasheedThamir M AlshammariPublished in: Pharmacoepidemiology and drug safety (2022)
The results of our study showed that the SFDA decision was associated with a decrease in the overall use of pregabalin, which may help minimize the risk of its abuse and misuse.